Latest Breakthroughs in Alzheimer’s Research

A global first Alzheimer’s study needs trial participants. Professor John Mamo from Curtin University and the Perron Institute for Neurological and Translational Science explained who is eligible for the trial.

The Perron Institute’s capability in neurosciences has been further strengthened by the appointment of John Curtin Distinguished Professor John Mamo to facilitate translational research on Alzheimer’s disease and other neurological disorders.

Groundbreaking research identifies a likely cause of Alzheimer’s disease, opening avenues for new prevention and treatment options for Australia’s second-leading cause of death.

Professor John Mamo has been named John Curtin Distinguished Professor for his pioneering Alzheimer's research, highlighting his dedication to advancing neurological science and improving patient outcomes.

Professor John Mamo's research project has received $1.72 million to trial a new Alzheimer's treatment. The drug aims to prevent brain capillary leakage and inflammation, potentially improving cognitive function in patients.

Join us at Have a Go Day, a LiveLighter event dedicated to promoting exercise, socialisation, and mental activity for the over-55s. Come by our marquee to chat with the PIA Perth Study clinical trial team and learn more about Alzheimer’s prevention and treatment options.

We hosted an information session at Manning Community Centre, sharing insights on Alzheimer's prevention and treatment. Attendees enjoyed a presentation, Q&A with experts, and a meet-and-greet.